Identifying the origins of cystic fibrosis lung disease

New England Journal of Medicine

Volumn 368, Issue 21, 2013, Pages 2026-2028

  Davis, Stephanie D ^a   Ferkol, Thomas ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; ELASTASE; PROTEINASE INHIBITOR;

BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; FAILURE TO THRIVE; HUMAN; LUNG FIBROSIS; LUNG LAVAGE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 84877953429     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1303487     Document Type: Editorial

References (10)

1. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994;150:448-54. [Erratum, Am J Respir Crit Care Med 1995;151:260.]
2. Nakamura H, Yoshimura K, McElvaney NG, Crystal RG. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992;89:1478-84.
3. Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990;86:300-8.
4. Hartl D, Latzin P, Hordijk P, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007;13:1423-30.
5. Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009;180:146-52.
6. Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009;155:623-8.
7. Sly PD, Gangell CL, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013;368:1963-70.
8. Rosenfeld M, Ratjen F, Brumback L, et al. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012; 307:2269-77.
9. McElvaney NG, Hubbard RC, Birrer P, et al. Aerosol alpha1- antitrypsin treatment for cystic fibrosis. Lancet 1991;337:392-4.
10. Griese M, Latzin P, Kappler M, et al. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J 2007;29:240-50.